Pharma Manufacturing

Menu

Newsletters
Subscribe

Newsletters
Subscribe

Follow us on:

Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sector

Home|
Solution Providers|
E-News|
Subscribe|
Resource Directory|
Webinars|
Current Issue

Follow us on:

On Pharma

No Child Left Behind?

Category: Miscellany

Submitted by pharmamanufacturing on Wed, 12/12/2007 - 12:57

Child healthcare bill veto expected.

Permalink

Show Comments

Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments

Most Popular

Past 7 Days
Past 30 Days
Past 6 Months

01

Top Novartis scientists exited company ahead of data scandal

More details are emerging about the months leading up to Novartis’s…
02

2019 Pharma Innovation Awards

This year's winners offer slices of innovation
03

Regeneron drug boosts survival of Ebola to 90 percent

A new study has shown that a pair of experimental treatments could…
04

Qualifying your cleanroom

Revised GMP guidelines will strengthen emphasis on contamination control,…
05

Natco Pharma API plant hit with Form 483

Natco Pharma has received a Form 483 with six observations from the U.S.

01

FDA says Novartis gene therapy drug application contains manipulated data

On May 24, the FDA approved Zolgensma, a gene therapy product intended to…
02

FDA accuses Indian company of shredding documents before inspection

With the FDA getting ready to knock on their door, officials at Strides…
03

What’s behind all the M&A deals in pharma?

As far as M&A deals go, 2019 has started off with a boom.
04

10 of the highest-paid CEOs in pharma
05

Celgene snags new approval for Otezla

Celgene announced that the U.S. FDA has approved Otezla for the treatment…

01

Merck to cut jobs, close plants with $1.2B restructuring plan

Merck and Co. has created a restructuring plan it says is designed to…
02

The Highest — and Lowest — Ranked Places to Work in Big Pharma

How pharma companies fair on Glassdoor.
03

Torrent hit with Form 483

The FDA found that in hundreds of cases, batches at Torrent’s plant did…
04

Anti-vaxxers turn to potatoes

A new and weird rumor has surfaced in the anti-vaccine movement: potatoes…
05

FDA says Novartis gene therapy drug application contains manipulated data

On May 24, the FDA approved Zolgensma, a gene therapy product intended to…

Pharma Manufacturing

About

General Information
Contact Us
Subscription Services
Media Kit
Editorial Calendar
Editorial Submissions Guidelines
Editorial Advisory Board

Content

Resource Libraries
OpEd
Fundamentals
News
Articles
White Papers
Products
All Star Innovators
Funny Pharm

Magazine

Subscribe (print)
Current Issue
Issue Archive

Site Tools

Site Map
Resource Directory

Stay Connected

My Account
Events Calendar
E-Newsletters
Human Interest
Facebook
Twitter
LinkedIn
YouTube
RSS Feed

Contact Us | Advertise | Privacy Policy | Legal Disclaimers, Terms & Conditions

Copyright © 2004 - 2019 Pharma Manufacturing. All rights reserved.

P: 630-467-1300 | 1501 E. Woodfield Road, Suite 400N, Schaumburg, IL 60173

Chemical Processing | Control | Control Design | Food Processing | Pharma Manufacturing | Plant Services | Smart Industry